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We isolated methicillin-resistant Staphylococcus
aureus (MRSA) from cows with subclinical mastitis and
from a person who worked with these animals. The bovine
and human strains were indistinguishable by phenotyping
and genotyping methods and were of a low frequency spa
type. To our knowledge, this finding indicates the first doc-
umented case of direct transmission of MRSA between
cows and humans.
Since the introduction of β-lactamase–stable antimicro-bial drugs into clinical use, methicillin-resistant
Staphylococcus aureus (MRSA) strains have emerged
worldwide as important nosocomial pathogens; their preva-
lence in the community is increasing substantially.
Although S. aureus is known to be one of the most common
causes of bovine mastitis and other severe animal diseases
such as septicemia and wound, bone, and joint infections,
MRSA strains have been rarely isolated from animals.
MRSA strains have been isolated from cows with mastitis,
horses and dogs with lesions, and dogs and cats that were
carriers (1). Transmission of MRSA between humans and
animals (e.g., dogs, horses, pigs) has been reported (2–4),
but transmission between cows and humans has not, to our
knowledge. We describe a first putative case of transmis-
sion of MRSA between cows and a person.
From January 2002 through December 2004, 595 milk
samples were collected from cows with subclinical masti-
tis on a farm in Hungary and sent for bacteriologic analy-
sis to the Bacteriological Department of the Hungarian
Central Veterinary Institute. Samples were streaked onto a
Columbia agar plate (Merck, Darmstadt, Germany) con-
taining 5% sheep blood and 0.01% esculin and a Baird-
Parker (BP) agar plate (Oxoid Ltd., Basingstoke,
England). After incubation at 37°C for 24 h, the colonies
were tentatively identified according to morphologic fea-
tures, pigment production, Gram stain results, catalase test
results, type of hemolysis, and characteristic growth on BP
agar. The isolates initially characterized as staphylococci
were tested for coagulase production (in tubes) and with
Slidex Staph Plus test (bioMérieux, Marcy l’Etoile,
France) to confirm their identification as S. aureus. From
this farm, 375 S. aureus strains were isolated. The strains
were tested for antimicrobial drug susceptibility, produc-
tion of β-lactamases, and presence of mecA by PCR (5).
The first MRSA strain was isolated in spring 2002; during
the next 15 months, 26 additional MRSA strains were iso-
lated from this dairy herd. 
In December 2002, tonsil swabs were collected once
from 12 workers on this farm who were in close contact
with the cows (veterinarian, milkmen, and attendants) and
who gave informed consent. (The study was approved by
the Ethical Committee of the National Center for
Epidemiology, Budapest, Hungary.) Culturing and identifi-
cation of S. aureus were carried out by the above-described
method. S. aureus was isolated from 3 samples. One of
these isolates was resistant to methicillin by disk diffusion
and E-test, and the presence of the mecA gene was con-
firmed by PCR. 
All 28 MRSA strains (27 bovine and 1 human) pro-
duced PBP2a, according to latex agglutination test (Oxoid
Ltd.). Eight of 27 randomly chosen bovine strains and the
human strain containing the mecA gene, as well as 4
bovine and 2 human mecA–negative isolates, were phage
typed with MRSA phages (6) at the Institute of National
Public Health and Medical Officers Service in Hajdú-
Bihar County. The phages were used in 2 concentrations:
routine test dilution (RTD), and 100× RTD. None of the
MRSA or methicillin-susceptible S. aureus (MSSA)
strains were lysed by phages in RTD. All MRSA strains
showed a similar lysis pattern with the 100× RTD MRSA
phages (Table). 
Susceptibilities to 7 antimicrobial agents were
assessed by a disk diffusion method that used the Clinical
and Laboratory Standards Institute (CLSI; formerly
National Committee for Clinical Laboratory Standards)
breakpoints for 7 mecA–positive bovine strains and the
human mecA–positive strain. All tested strains showed the
same susceptibility pattern (resistant to ampicillin,
cephalexin, tetracycline, and erythromycin and susceptible
to enrofloxacin, gentamicin, and trimethoprim/sul-
famethoxazole). Pulsed-field gel electrophoresis was per-
formed on the 7 mecA–positive bovine strains, 1 human
mecA–positive strain, 4 bovine MSSA strains, and 2
human MSSA strains, as described by McDougal et al. (7).
The patterns of the SmaI–digested DNA of the strains are
presented in the Figure. All bovine mecA–positive strains
and the human mecA–positive strain (human 3) showed
indistinguishable SmaI patterns. All mecA–negative iso-
lates showed a pulsed-field gel electrophoresis pattern dif-
ferent from that of the MRSA strains. 
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For further identification, 1 human and 4 bovine
MRSA isolates (29509, 24069/2, 24069/4, 30195; Table)
underwent spa typing (8). All these isolates showed spa-
type t127. Because the strains were indistinguishable by all
methods, multilocus sequence typing (MLST) (9) and typ-
ing of the staphylococcal cassette chromosome (SSCmec)
(10) were performed on just 1 strain (29509). This strain
showed MLST sequence type (ST) 1 and SCCmec type
IVa. The strain did not carry the Panton-Valentine leuko-
cidin (PVL) toxin genes lukF–lukS as tested by PCR (11).
In this study, both phenotyping and genotyping
showed that the MRSA isolates of bovine origin and the
single human isolate were indistinguishable. The database
of the European network for spa typing (www.seqnet.org)
shows that MLST ST 1/spa-type t127 has a relative global
frequency of 0.7%; according to this database, this type
has not previously been reported in Hungary. A study of
135 human MRSA isolates collected in Hungary during
2001–2004 showed human epidemic clones of types other
than ST 1 and spa-type t127 (12). We conclude that the
bovine and human MRSA strains described in our study
are epidemiologically related, which indicates transmis-
sion from either cow to human or human to cow. This
strain is negative for the PVL genes, which differentiates it
from community-associated MRSA ST 1, which is positive
for PVL genes (11). 
Several cows had positive test results for MRSA,
which indicated that MRSA was spread within the farm.
On the farm, cases of clinical mastitis were treated with
intramammary infusions containing penicillin, aminopeni-
cillins, or cephalosporins. Each cow also received drying-
off therapy with cloxacillin or cephalosporins. The use of
antimicrobial drugs may have contributed to the emer-
gence of MRSA in this dairy farm. 
MSSA strains with ST 1 and spa-type t127 have been
reported from human sources (13). MSSA strains may be
induced to pick up the mecA gene from coagulase-negative
staphylococci. Alternatively, mastitis may be caused by
human MRSA strains or bovine MRSA strains already
present in small numbers and selected for by the frequent
use of long-acting antimicrobial preparations, especially
β-lactams. S. aureus usually shows limited host specifici-
ty, and transfer between different host species may occur
(14). The transmission of milk-associated S. aureus strains
between cows and humans was suggested by Lee (15),
whose study showed MRSA in milk samples with compa-
rable antibiotypes as those in humans, but the transfer to
humans was not proven. The risk for spread of MRSA
from bovine sources into the human population is low.
Generally, persons are not at risk as long as raw milk is not
consumed. However, persons in close contact with MRSA-
infected cattle, including veterinarians, farmers, milkers,
and persons working at slaughterhouses, may become col-
onized from the bovine source.
We conclude that several cases of subclinical mastitis
in cows on a farm in Hungary were caused by MRSA and
that these strains were indistinguishable from MRSA iso-
lated from a carrier working in close contact with the
cows. This suggests the transmission of these isolates
between humans and cows, although the direction of trans-
fer (cow to human or human to cow) could not be proven.
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Figure. Pulsed-field gel electrophoresis patterns of SmaI-digested
DNA of bovine and human strains of Staphyloccocus aureus iso-
lated from cows with subclinical mastitis, Hungary, January
2002–December 2004. Strains are numbered as shown in Table.
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Hungarian national antibiotic resistance monitoring system,
based on samples from healthy slaughter animals, and since 2001
has coordinated this system.
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